Key Features
SBRI Healthcare is inviting applications that address challenges in respiratory diseases and prevention of cardiovascular diseases.
Programme: SBRI
Award: Share of up to £500,000
Opens: 14th Jun 2022
Closes: 26th Jul 2022
SBRI Healthcare is an NHS England & NHS Improvement initiative, supported by the Academic Health Science Network (AHSN) and managed by LGC Group. SBRI aim to promote UK economic growth whilst addressing unmet health needs and enhancing the take up of known best practice.
SBRI Healthcare is delighted to invite applications to tender for projects to implement medical devices, in vitro diagnostics, digital health solutions, behavioral interventions, software, artificial intelligence, and new models of care to address challenges in the following themes:
Respiratory diseases
Prevention of cardiovascular diseases
Evidence-based and cost-effective interventions often fail to be implemented into routine health and social care practices, a challenge which could be addressed by real-world validation of innovations in their intended setting.
Clear articulation of the clinical benefits alongside the costs analysis can facilitate the integration of evidence-based practice. The SBRI Healthcare Programme is committed to supporting the NHS in delivering the objectives of the NHS LTP. In providing funding for implementation studies that generate the evidence necessary for uptake, the access to and reach of innovations will be accelerated for the benefit of patients.
The competition is open to single companies or organisations from the private, public, and third sectors, including charities.
The SBRI Healthcare Programme Management Office is available to answer any questions you may have about the competition and starting your application.
Sign up for the SBRI briefing webinar here
All proposals should also be aware that the following will also be excluded:
● Basic research and innovations in the creation phase.
● Systems and solutions that will not easily integrate or communicate with NHS/community setting systems. Some evidence of interoperability and/or work to assess this will be required.
● Technologies that do not comply with GDPR policies.
● Technologies that may increase burden on the workforce.
● Technologies that will increase health inequalities (including digital exclusion or data inequalities) and inequity of access to care e.g., digital technologies that are inaccessible to certain communities that experience digital poverty.
● Innovations that are not co-designed with patients and end users.
With reference to the individual challenges, the following technologies will be considered out of remit:
Respiratory Disease
● Innovations focussed on lung cancer, particularly on early diagnosis.
● Apps that provide general wellbeing and lifestyle change recommendations without clinical evidence to support their benefits.
● Wearables or monitoring apps (e.g. measuring physiological signs using combined technologies) that do not have a clinicians’ interface and input.
The Phase 3 Funding Competition runs in one phase only and is intended to facilitate the implementation of developed innovations. The contracts placed will be for a maximum of 12 months and up to £500,000 (NET) per project.
The implementation will be 100% funded and suppliers for each project will be selected by an open competition process and retain the intellectual property rights (IPR) generated from the project, with certain rights of use retained by the NHS.
Book an appointment to speak to one of our advisors to discuss your eligibility to apply for this Grant Funding opportunity.
Call 
Back
